Gene · 4605
Papers2,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma. | Genes Dis | 2024 | 37692491 | PubTator, text mining | PubMed |
| Ribonucleotide reductase M2 (RRM2): Regulation, function and targeting strategy in human cancer. | Genes Dis | 2024 | 37588202 | PubTator, text mining | PubMed |
| Current Research on Molecular Biomarkers for Colorectal Cancer in Stool Samples. | Biology (Basel) | 2023 | 38248446 | PubTator, text mining | PubMed |
| Prediction of Chemoresistance-How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer. | Curr Oncol | 2023 | 38248100 | PubTator, text mining | PubMed |
| Biomarkers in Cancer Detection, Diagnosis, and Prognosis. | Sensors (Basel) | 2023 | 38202898 | PubTator, text mining | PubMed |
| Update on current diagnosis and management of anaplastic thyroid carcinoma. | World J Clin Oncol | 2023 | 38179406 | PubTator, text mining | PubMed |
| Identification of potential key genes for colorectal cancer based on bioinformatics analysis. | Medicine (Baltimore) | 2023 | 38134110 | PubTator, text mining | PubMed |
| Somatic Copy Number Alterations in Colorectal Cancer Lead to a Differentially Expressed ceRNA Network (ceRNet). | Curr Issues Mol Biol | 2023 | 38132443 | PubTator, text mining | PubMed |
| An exosome-based specific transcriptomic signature for profiling regulation patterns and modifying tumor immune microenvironment infiltration in triple-negative breast cancer. | Front Immunol | 2023 | 38124743 | PubTator, text mining | PubMed |
| Bioinformatics-based analysis of the relationship between disulfidptosis and prognosis and treatment response in pancreatic cancer. | Sci Rep | 2023 | 38097783 | PubTator, text mining | PubMed |
| Enhanced fetal hematopoiesis in response to symptomatic SARS-CoV-2 infection during pregnancy. | Commun Med (Lond) | 2023 | 38082066 | PubTator, text mining | PubMed |
| Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis. | Int J Mol Sci | 2023 | 38068961 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Native Kentucky Bluegrass (Poa pratensis L.) in Response to Osmotic Stress. | Plants (Basel) | 2023 | 38068609 | PubTator, text mining | PubMed |
| Bioinformatics analysis-based screening of circRNA gene with mainstream expression trend in colorectal cancer and construction of a coexpression regulatory network. | PLoS One | 2023 | 38064496 | PubTator, text mining | PubMed |
| Integrated analysis identities Rho GTPases related molecular map in patients with gastric carcinoma. | Sci Rep | 2023 | 38052924 | PubTator, text mining | PubMed |
| FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe. | Cancer Res Commun | 2023 | 38032106 | PubTator, text mining | PubMed |
| Machine learning-based models for the prediction of breast cancer recurrence risk. | BMC Med Inform Decis Mak | 2023 | 38031071 | PubTator, text mining | PubMed |
| SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma. | Nat Commun | 2023 | 38030644 | PubTator, text mining | PubMed |
| HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis. | Nat Commun | 2023 | 38030596 | PubTator, text mining | PubMed |
| Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research. | Front Mol Biosci | 2023 | 38028543 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4605/papers?page=10